Johnson & Johnson stock faces Tuesday test after fresh talc verdict as dividend date nears
A Pennsylvania jury found Johnson & Johnson liable in a baby powder talc cancer case, awarding $250,000 to the plaintiff’s family. Shares closed at $243.45 Friday, down 0.45%. U.S. markets are closed Monday for Presidents Day. The company plans to appeal the verdict and faces over 67,000 similar lawsuits.